Search Results for: cronos
Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022…
Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022…
Cronos Group Reports 2021 Fourth Quarter and Full-Year Results
Consolidated net revenue increased 59% in Full Year 2021 compared to Full Year 2020 Announces…
Cronos Group Inc. to Hold 2021 Fourth Quarter and Full-Year Earnings Conference Call on March 1, 2022
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its…
Cronos Group Reports 2021 Third Quarter Results
Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements Announces strategic realignment…
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”), the Canadian company defining the future of cannabinoids worldwide,…
Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group
Aurora Cannabis Inc. (NASDAQ | TSX: ACB) (“Aurora”), the Canadian company defining the future of…
Cronos Group Provides Bi-Weekly MCTO Status Update and Announces Receipt of Nasdaq Listing Delinquency Letter
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) is providing a…
Cronos Group Files Form 12b-25
Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) today announced that…
Cronos Group Chief Innovation Officer Dr. Todd Abraham to Retire
Arye Weigensberg Named Interim Head of Research and Development Search to Identify Permanent Successor Well…
Recent Comments